We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Youths receiving tirzepatide had a 2.28 percentage point ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In ATTAIN-2, adults receiving 36 mg orforglipron lost a ...
NEW YORK--(BUSINESS WIRE)--Unite Us, the nation’s trusted technology partner for integrating health and community-based care, reports significant health improvements from a year-long collaboration ...
Rate of combined clinically significant or severe hypoglycemia significantly lower with efsitora versus glargine. (HealthDay News) — Once-weekly insulin efsitora alpha (efsitora) is noninferior to ...
For adults with stage 4-5 CKD, an HbA1c range of 6.7% to 7.1% may be optimal for reducing macrovascular and microvascular complications. In advanced chronic kidney disease (CKD) and diabetes (type 1 ...
Medpage Today on MSN
Novel Berberine Drug Cut HbA1c in Type 2 Diabetes
An investigational compound incorporating an herbal-based supplement improved blood glucose in adults with inadequately ...
Tirzepatide (Mounjaro) improved glucose control and body mass index (BMI) in children with type 2 diabetes who were inadequately controlled with metformin and basal insulin, the phase III SURPASS-PEDS ...
Stable housing is linked to modest improvements in HbA1c, blood pressure, and cholesterol levels in T2D patients. The study used electronic health records from US community health centers, focusing on ...
A clinical trial to test the effectiveness of a new, plant-based oral drug to treat type 2 diabetes has produced some promising results. The drug significantly improved blood glucose control and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback